You are here

Alibaba's health shift prescribes market medicine

nz_alibaba_060382.jpg
Alibaba's new health priorities come at the right time. The e-commerce group is injecting more assets into its healthcare subsidiary, now worth a punchy US$25 billion. It's a timely bet that the coronavirus will accelerate reforms, like opening China's US$370 billion drug industry to Web retailers.

[HONG KONG] Alibaba's new health priorities come at the right time. The e-commerce group is injecting more assets into its healthcare subsidiary, now worth a punchy US$25 billion. It's a timely bet that the coronavirus will accelerate reforms, like opening China's US$370 billion drug industry to...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes